Amarin Co. plc (NASDAQ: AMRN) had its "buy" rating re-affirmed by analysts at HC Wainwright.
Last amarin corp plc ads earnings: 4/30 05:00 am
Check Earnings Report
US:NASDAQ Investor Relations: investor.amarincorp.com/investors
| Impact snapshot | Event time: | AMRN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
AMRN alerts
AMRN alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMRN alerts
High impacting Amarin Corp Plc ADS news events
Weekly update
A roundup of the hottest topics
AMRN
News
- U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents [Financial Post (Toronto, Ontario, Canada)]Financial Post
- U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents [Financial Post (Toronto, Ontario, Canada)]Financial Post
- U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents [Reuters]Reuters
- Amarin Co. plc (<a href="https://www.marketbeat.com/stocks/NASDAQ/AMRN/price-target/">NASDAQ: AMRN</a>) had its "buy" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $10.00 price target on the stock.MarketBeat
- Amarin Corporation plc (AMRN) CEO John Thero Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript) [Seeking Alpha]Seeking Alpha
- More
AMRN
SEC Filings
- 6/16/21 - Form 4
- 6/16/21 - Form 4
- 6/16/21 - Form 4
- AMRN's page on the SEC website
- More